MINAPHARM Pharmaceuticals's latest marketcap:
As of 08/14/2025, MINAPHARM Pharmaceuticals's market capitalization has reached $57.31 M. According to our data, MINAPHARM Pharmaceuticals is the 29188th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 57.31 M |
| Revenue (ttm) | 130.18 M |
| Net Income (ttm) | 3.43 M |
| Shares Out | 11.78 M |
| EPS (ttm) | 0.31 |
| Forward PE | 0.00 |
| Ex-Dividend Date | 08/13/2025 |
| Earnings Date | 08/11/2025 |
MINAPHARM Pharmaceuticals's yearly market capitalization.
| Date | Market Cap | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 08/14/2025 | 2.77 B | $57.31 M | 56.33% | 29188 |
| 12/31/2024 | 1.8 B | $34.44 M | -25.41% | 30565 |
| 12/31/2023 | 2.41 B | $76.61 M | 32.19% | 24871 |
| 12/29/2022 | 1.82 B | $72.73 M | 39.82% | 24342 |
| 12/30/2021 | 1.3 B | $82.38 M | 32.02% | 24362 |
| 12/31/2020 | 987.04 M | $62.28 M | -5.49% | 23419 |
| 12/31/2019 | 1.04 B | $64.61 M | -3.47% | 20463 |
| 12/31/2018 | 1.08 B | $59.92 M | 9.58% | 19990 |
| 12/31/2017 | 987.29 M | $54.91 M | 13.79% | 21053 |
| 12/20/2016 | 867.67 M | $46.46 M | 132.48% | 19712 |
Company Profile
About MINAPHARM Pharmaceuticals
MINAPHARM Pharmaceuticals is a leading producer of medicines, medical and dental supplies, and dietary supplements, operating in Egypt and internationally. Established in 1958, the company is headquartered in Cairo, Egypt.
Product Portfolio
MINAPHARM offers a diverse range of pharmaceutical solutions, including:
- Human & Veterinary Medicines: Treatment for hematoma, thrombosis, iron deficiency anemia, and more.
- Herbal Medicines: Natural remedies for various health conditions.
- Specialized Treatments: Solutions for osteoporosis, rheumatoid arthritis, hyperlipidemia, and diabetic neuropathy.
- Ophthalmic & Dermatological Care: Products for dry eye, skin infections, and ocular inflammation.
- Women's Health: Antifungals and treatments for vaginal infections.
- Gastrointestinal & Hepatology: Medications for nausea, vomiting, and liver conditions.
- Cardiovascular & Respiratory: Treatments for coronary heart disease and respiratory infections.
- Surgical & Hemostasis: Products for surgical dressing and hemorrhage control.
Commitment to Health
With decades of expertise, MINAPHARM Pharmaceuticals remains dedicated to improving global health through innovative and high-quality pharmaceutical solutions.
Frequently Asked Questions
-
What is MINAPHARM Pharmaceuticals's (EGX-MIPH) current market cap?As of 08/14/2025, MINAPHARM Pharmaceuticals (including the parent company, if applicable) has an estimated market capitalization of $57.31 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does MINAPHARM Pharmaceuticals (EGX-MIPH) rank globally by market cap?MINAPHARM Pharmaceuticals global market capitalization ranking is approximately 29188 as of 08/14/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.